Fibrous plaques develop when the body’s wound-healing machinery overreacts, laying down dense collagen and scar tissue in places it does not belong. In arteries, these plaques grow inside vessel walls during atherosclerosis, gradually narrowing the channel that carries blood. In Peyronie’s disease, a similar fibrotic process builds a hard plaque inside the connective tissue sheath of the penis, bending it and sometimes causing pain. Though the two conditions affect very different anatomy, they share a surprising amount of biology: the same inflammatory signals, the same growth factor (TGF-β), and many of the same systemic risk factors show up in both.
How Arterial Fibrous Plaques Begin
An arterial fibrous plaque is not something that appears overnight. It starts with damage to the endothelium, the single-cell-thick lining that separates flowing blood from the artery wall. High blood pressure, smoking, high cholesterol, and high blood sugar all chip away at this lining over years. Once the endothelium is compromised, it becomes leaky. Cholesterol-carrying particles, especially LDL, slip through into the artery wall, where they do not belong.1Free Radical Biology and Medicine. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis
What follows is an escalating cascade. The body treats that trapped LDL as a foreign invader. White blood cells, particularly macrophages, swarm into the area and start swallowing the lipid deposits. These fat-laden macrophages, called foam cells, form the core of an early plaque. Over time, more lipids accumulate, fibrous tissue is laid down on top, and the plaque stiffens and grows. The whole process involves lipid buildup, fibrous-tissue formation, and eventually calcification, leading to a progressively narrower artery.2PubMed Central. Pathophysiology of Atherosclerosis
The Role of Smooth Muscle Cells
The fibrous cap that gives these plaques their name is built largely by smooth muscle cells in the artery wall. Under normal conditions, these cells contract and relax to regulate blood flow. But when an artery is injured, smooth muscle cells undergo a dramatic identity shift. They stop behaving like muscle and start behaving like construction workers: migrating toward the injury, multiplying, and pumping out collagen and other structural proteins.3PubMed Central. How vascular smooth muscle cell phenotype switching contributes to vascular disease
This “phenotype switching” is a normal part of wound repair, but in atherosclerosis it never fully turns off. The ongoing irritation from trapped lipids and inflammatory signals keeps the smooth muscle cells in their construction-worker mode. Some of them even take on characteristics of bone-forming cells or immune cells, adding to the complexity and stubbornness of the plaque.4PubMed Central. Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis Recent research has shown that in women, this smooth-muscle-driven tissue remodeling is especially prominent in the fibrous cap and is closely tied to TGF-β signaling, the same growth factor at the center of fibrotic disease throughout the body.5PubMed Central. Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-β
Macrophages and the Inflammatory Feedback Loop
Macrophages do more than just eat lipids. Once inside the plaque, they release inflammatory molecules that recruit still more immune cells, creating a self-reinforcing cycle. This chronic inflammation is what distinguishes a dangerous plaque from a harmless fatty streak. Macrophages in plaques show extreme variability in their behavior: some promote inflammation, others try to resolve it, and many end up dying inside the plaque, adding to a growing necrotic core underneath the fibrous cap.6Cell Death & Disease. Macrophage polarization and metabolism in atherosclerosis
As the inflammatory environment persists, cells in and around the plaque become senescent, meaning they stop dividing but refuse to die. These senescent cells release their own cocktail of inflammatory signals, spreading dysfunction to neighboring healthy cells and pushing the plaque toward instability. A plaque with a thin, inflamed fibrous cap and a large necrotic core is the kind most likely to rupture, which is what triggers heart attacks and strokes.
Calcification and Why Plaques Harden
Many people think of arterial plaques as soft, greasy deposits. Some are, but advanced fibrous plaques often contain mineral deposits of hydroxyapatite, the same calcium-based mineral found in bone. This is not passive calcium buildup from hard water or too many supplements. Research has shown that the artery wall contains bone-related proteins and even cells capable of forming mineral, similar to the way bone tissue develops. A key signal, bone morphogenetic protein 2a, has been found in calcified human plaques, suggesting that the artery is actively undergoing a bone-formation-like process.7PubMed. Mechanism of calcification in atherosclerosis
Calcification changes the mechanical properties of a plaque. Heavily calcified plaques are stiff and less likely to rupture, which is why doctors sometimes view extensive calcification as a sign of stable (though advanced) disease. Spotty, patchy calcification within a softer plaque, on the other hand, can create stress points that make rupture more likely. The pattern of calcification matters as much as the amount.
Key Risk Factors for Arterial Plaques
The major risk factors for atherosclerosis divide into things you cannot change and things you can. Age, sex, and genetic predisposition fall into the first category. High blood pressure, smoking, physical inactivity, poor diet, diabetes, high cholesterol, and obesity fall into the second. Among the modifiable factors, hypertension stands out as the most widespread contributor to plaque development.8PubMed Central. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
High blood pressure does not just push harder against artery walls mechanically. It also amplifies the damage caused by other risk factors. When elevated blood pressure combines with high cholesterol, for example, the resulting oxidative stress on the artery lining is worse than either factor would produce alone.9PubMed. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective This synergy is one reason cardiovascular risk scores consider multiple factors together rather than evaluating each one in isolation.
How Peyronie’s Disease Plaques Form
Peyronie’s disease affects the tunica albuginea, the tough, elastic sheath that surrounds the erectile chambers of the penis. Injury, often minor enough that a person never notices it, sets the process in motion. During erection, the tunica albuginea is under considerable mechanical stress, and small tears or microvascular injuries can occur during sexual activity or other physical contact. These micro-injuries trigger bleeding into the tissue layers, and the body begins its standard repair response.10PubMed Central. Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up
Electron microscopy of Peyronie’s plaques reveals inflammatory infiltration of the tunica albuginea, disorganized extracellular matrix, proliferating fibroblasts, and dense collagen deposits, essentially the same tissue-level picture you see in fibrotic disease elsewhere in the body.11PubMed. Supporting the role of penile trauma and micro-trauma in the etiology of Peyronie’s disease The resulting plaque is not cancerous. It is scar tissue that formed in the wrong place, in the wrong amount, and failed to remodel itself back to normal.
Fibrin Trapping and Repair Gone Wrong
The critical moment in Peyronie’s disease is what happens to fibrin, the protein mesh the body uses to form clots and seal wounds. When the tunica albuginea tears, fibrin leaks into the surrounding tissue as part of normal healing. In most people, the body clears the fibrin once the wound closes. In Peyronie’s disease, the fibrin is not adequately cleared. It stays trapped in the tissue space, and its presence activates fibroblasts, which start producing collagen. The fibroblasts proliferate, blood vessel permeability increases, and inflammatory cells are drawn in by chemical signals from the lingering fibrin.12PubMed. Proposal: trauma as the cause of the Peyronie’s lesion
Fibrin deposits have been directly confirmed in Peyronie’s plaque tissue, consistent with the idea that repeated microvascular injury drives the disease.13PubMed. Fibrin deposition in Peyronie’s disease plaque If further trauma occurs before the first injury has healed, more fibrin is deposited, and the cycle intensifies. This is why the condition tends to be progressive in its early phase: each re-injury compounds the problem. TGF-β1, synthesized in response to the initial injury, further accelerates collagen production and fibrosis.14Nature Clinical Practice Urology. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie’s disease
Oxidative Stress as an Accelerant
The inflammatory process in Peyronie’s disease generates large amounts of reactive oxygen species, the same free radicals implicated in arterial damage. When the tunica albuginea tears, the resulting small hematoma triggers an inflammatory cascade. Inflammatory cells produce reactive oxygen species, and a key signaling pathway involving nuclear factor kappa-B kicks in. This leads to excessive nitric oxide production and the formation of peroxynitrite, a particularly destructive oxidant. The end result is unchecked fibroblast and myofibroblast proliferation and excessive collagen deposition between the layers of the tunica albuginea.15PubMed. Inflammatory mechanisms and oxidative stress in Peyronie’s disease: therapeutic “rationale” and related emerging treatment strategies
Oxidative stress is increasingly recognized as a central component of all chronic inflammatory processes, including fibrotic ones.16PubMed Central. Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants This has led some researchers to explore antioxidant therapies for early-stage Peyronie’s disease, though the evidence for their effectiveness remains limited.
TGF-β as the Common Thread
If there is one molecule that ties arterial fibrosis to Peyronie’s disease, it is transforming growth factor-beta, or TGF-β. This signaling protein is one of the body’s most powerful drivers of fibrosis. When tissue is injured, TGF-β tells fibroblasts to produce collagen and tells other cells to stop breaking it down. In a well-regulated wound, TGF-β activity winds down once the repair is complete. In fibrotic disease, the signal stays on.17PubMed Central. Transforming growth factor-β in tissue fibrosis
In arterial plaques, TGF-β drives the smooth muscle cells that build the fibrous cap and promotes the tissue remodeling that stiffens the vessel. In Peyronie’s disease, TGF-β1 is synthesized after penile injury and pushes the fibroblasts in the tunica albuginea toward excessive collagen production. The downstream pathways are similar in both cases, which is why drugs that target TGF-β signaling are being investigated for multiple fibrotic conditions simultaneously.
Shared Risk Factors Between Arterial and Penile Plaques
The overlap in risk factors between atherosclerosis and Peyronie’s disease is hard to ignore. In a study of men with Peyronie’s disease, the most common accompanying conditions were hypertension (found in about 27% of cases), smoking (about 26%), high cholesterol (about 18%), and diabetes (about 17%).18PubMed. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie’s disease These are the same metabolic and vascular risk factors that drive arterial plaque formation. Further studies in diabetic men being screened for erectile dysfunction confirmed significant associations between Peyronie’s disease and age, obesity, smoking, and dyslipidemia.19PubMed. Peyronie’s disease in diabetic patients being screened for erectile dysfunction
A study measuring vascular function directly found that men with Peyronie’s disease had impaired endothelium-dependent blood vessel dilation compared to controls, even after adjusting for other risk factors.20PubMed. Systemic vascular endothelial dysfunction in Peyronie’s disease This suggests the endothelial dysfunction is not just a coincidence of shared risk factors but may be mechanistically involved. A vascular system that is already damaged at the cellular level may be less capable of properly healing the kind of microtrauma that triggers Peyronie’s disease.
The Dupuytren’s Connection and Other Fibrotic Conditions
Peyronie’s disease does not always occur in isolation. It clusters with other fibrotic disorders, most notably Dupuytren’s contracture, a condition in which thick cords of tissue form in the palm and pull the fingers into a bent position. A cross-sectional study from a tertiary andrology center found that Peyronie’s disease in men with Dupuytren’s contracture was significantly associated with bilateral Dupuytren’s, diabetes, lower HDL cholesterol, and higher fasting glucose and HbA1c levels.21PubMed Central. Prevalence and clinical correlates of Peyronie’s disease in patients with Dupuytren’s disease: a cross-sectional study from a tertiary andrology center
The co-occurrence of these fibrotic conditions in the same patients, often alongside metabolic disorders, points to a systemic susceptibility to fibrosis rather than purely local causes. A man with Dupuytren’s and poorly controlled blood sugar may simply have a body that is primed to over-scar when given any provocation, whether in the hand, the penis, or the arteries.
Genetics and Immune Markers
The question of whether Peyronie’s disease has a genetic component has been explored for decades. Early work suggested a link to certain immune-system markers (HLA antigens). One study found that antigens from the HLA-A1, B8, DR3, and DQw2 haplotype were overrepresented in men with Peyronie’s disease, hinting at autoimmune involvement.22PubMed. HLA association of idiopathic Peyronie’s disease: an indication of autoimmune phenomena in etiopathogenesis? However, subsequent studies have largely failed to confirm earlier associations between specific HLA antigens and the disease. Family clustering has been documented, but the patterns suggest that any genetic contribution involves multiple genes rather than a single inherited marker.23PubMed Central. The Genetic Basis of Peyronie’s Disease: A Review
The upshot is that genetics probably raises a person’s susceptibility to Peyronie’s disease without determining it outright. A man with a family history of fibrotic conditions and multiple vascular risk factors faces a higher likelihood, but no single gene test can predict who will develop the disease.
Hormones and Penile Fibrosis
Testosterone plays a protective role in maintaining the health of penile connective tissue. A study examining the relationship between testosterone, age, and penile fibrosis found a strong association among testosterone deficiency, cavernosal fibrosis, and erectile dysfunction. Declining testosterone levels with age appear to contribute to the fibrotic changes in penile tissue that make conditions like Peyronie’s disease more likely.24PubMed Central. Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men
This does not mean that testosterone replacement prevents Peyronie’s disease. But it adds another layer to the picture: aging men with falling testosterone levels lose some of the tissue-maintenance signals that keep connective tissue elastic and properly remodeled. Combined with the accumulated vascular damage from years of hypertension or high cholesterol, the stage is set for abnormal scarring when injury occurs.
Diagnosing Peyronie’s Plaques
Most men with Peyronie’s disease notice a curve in the erect penis, sometimes accompanied by a palpable hard spot. Doctors confirm the diagnosis with ultrasound, which is the most reliable imaging tool for this condition. Ultrasound detects calcified plaques with perfect sensitivity and can also identify non-calcified plaques and measure them precisely.25PubMed Central. Imaging modalities and clinical assesment in men affected with Peyronie’s disease The type and direction of curvature varies. Dorsal curves (bending upward) are the most common pattern, followed by lateral bends. Different curvature types are associated with different vascular profiles: hourglass-shaped deformities, for instance, tend to have the worst arterial blood flow, while ventrolateral curves tend to have the most normal vascular function.26The Journal of Urology. The relationship between the type of penile abnormality and penile vascular status in patients with peyronie’s disease
This vascular profiling matters because it helps predict whether erectile dysfunction is caused by the plaque itself or by an underlying blood-flow problem. A man with a ventral curve and poor venous function may need different treatment than one with a dorsal curve and healthy blood vessels.
Emerging Treatments for Peyronie’s Plaques
For years, surgical options for Peyronie’s disease have been limited and imperfect. Early plaque-excision-and-grafting procedures left only about 30% of patients sexually functional afterward, which understandably made many men reluctant to pursue surgery.27PubMed. Peyronie’s plaque: excision and graft versus incision and stent Modern surgical techniques have improved considerably, but the field has also been exploring less invasive approaches.
One promising direction involves collagenase, an enzyme that breaks down collagen. Researchers have developed collagenase-loaded nanocapsules that protect the enzyme’s activity for about ten days, compared to roughly two days for unprotected collagenase. In laboratory testing on actual Peyronie’s plaque tissue from patients, a single injection of these nanocapsules reduced plaque weight by about 30% and significantly decreased collagen content. The nanocapsules were selectively toxic to myofibroblasts, the overactive scar-producing cells, while leaving normal fibroblasts unharmed.28PubMed. Collagenase nanocapsules for the treatment of Peyronie’s disease. Evaluation in fibrotic plaques obtained from human patients This kind of targeted approach could eventually offer a middle ground between watchful waiting and surgery, though clinical trials in humans are still needed.
The overlap between arterial and penile fibrous plaques has broader implications for treatment strategy. Because the same inflammatory and fibrotic pathways drive both conditions, managing systemic risk factors like blood pressure, blood sugar, and cholesterol is not just about preventing heart disease. It may also reduce a man’s vulnerability to fibrotic conditions like Peyronie’s disease. That connection is still being explored, but the biological logic is becoming harder to dismiss.